首页 | 本学科首页   官方微博 | 高级检索  
     

急性冠脉综合症患者血清基质金属蛋白酶水平变化及阿托伐他汀治疗对蛋白酶的影响
引用本文:孙洪涛,郭翼茹. 急性冠脉综合症患者血清基质金属蛋白酶水平变化及阿托伐他汀治疗对蛋白酶的影响[J]. 内蒙古民族大学学报(自然科学版), 2004, 19(5): 558-561
作者姓名:孙洪涛  郭翼茹
作者单位:1. 内蒙古民族大学,附属医院,内蒙古,通辽,028000
2. 通辽市铁路医院内科,内蒙古,通辽,028000
摘    要:通过检测血清基质金属蛋白酶(MMPs)水平,探讨此酶与急性冠脉综合征(ACS)患者临床危险度的关系,观察阿托伐他汀治疗对MMPs的影响.结果表明,急性冠脉综合征病人血清活性MMPs水平明显升高,酶原及升高的活性MMPs水平与ACS危险度无线形相关.阿托伐他汀治疗抑制MMPs的活性,可能是其稳定粥样斑块的机制之一.MMPs是有前途的监测斑块进展的血清学指标。

关 键 词:治疗  MMP  阿托伐他汀  患者  基质金属蛋白酶  血清  急性冠脉综合症  清基  活性  线形
文章编号:1671-0185(2004)05-0558-04
修稿时间:2004-05-18

The Change of Serum MMPs in Patients with ACS and the Effect of Atorvastatin Treatment on Levels of Serum MMPs
SUN Hong-tao,GUO Yi-ru. The Change of Serum MMPs in Patients with ACS and the Effect of Atorvastatin Treatment on Levels of Serum MMPs[J]. Journal of Inner Mongolia University for the Nationalities(Natural Sciences), 2004, 19(5): 558-561
Authors:SUN Hong-tao  GUO Yi-ru
Affiliation:SUN Hong-tao~1,GUO Yi-ru~2
Abstract:Thread detect levels of MMPs in patients with acute coronary syndrome,discuss relation the enzymes with degree of clinic risk in patients with acute coronany syndrome,the effect of atorvastatin treatment on levels of serum MMPs.The result showed:increased serum level of activity MMPs was detected in patients with ACS,In addition,level of activity MMPs was decreased by statins therapy,this result suggests a novel meachanics by which lipid flowering stablilize vulnerable plaques by reduced expression and activity of MMPs that degrade the arterial extracellular matrix and render atheroma less susceptible to disruption and thrombosis.
Keywords:Acute coronary syndromes (ACS)  Statins Metalloproteinase
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号